MCMedicalCodingSoftware
J9066

J9066: Injection, bendamustine hydrochloride (avyxa), 1 mg

HCPCSActiveBETOS O1D

J9066 is a HCPCS Level II code for injection, bendamustine hydrochloride (avyxa), 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

The CMS record for J9066

Long descriptor
Injection, bendamustine hydrochloride (avyxa), 1 mg

The official wording. This is what the code means.

Short descriptor
Inj bendamustine, avyxa 1mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2026

When CMS introduced the code.

BETOS
O1D

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J9066

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J9066 is not quite right, the correct code is very often within a few positions of it.

  • J9058Injection, bendamustine hydrochloride (apotex), 1 mgterminated
  • J9059Injection, bendamustine hydrochloride (baxter), 1 mgterminated
  • J9060Injection, cisplatin, powder or solution, 10 mg
  • J9061Injection, amivantamab-vmjw, 2 mg
  • J9062Injection, amivantamab 5 mg and hyaluronidase-lpuj
  • J9063Injection, mirvetuximab soravtansine-gynx, 1 mg
  • J9064Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg
  • J9065Injection, cladribine, per 1 mg
  • J9070Cyclophosphamide, 100 mgterminated
  • J9071Injection, cyclophosphamide (auromedics), 5 mg
  • J9072Injection, cyclophosphamide (frindovyx), 5 mg
  • J9073Injection, cyclophosphamide (dr. reddy's), 5 mg
  • J9074Injection, cyclophosphamide (sandoz), 5 mg
  • J9075Injection, cyclophosphamide, not otherwise specified, 5 mg
  • J9076Injection, cyclophosphamide (baxter), 5 mg
  • J9098Injection, cytarabine liposome, 10 mgterminated
HCPCS Level II2026Q4-Oct· effective October 1, 2026